Description

Opioid receptor cross-talk with cannabinoid signaling in the context of seizure control is illustrated. Mu and kappa opioid receptors may modulate phytocannabinoid efficacy.

Figure 487

Diagram

Source Paper

Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy.

Pharmaceuticals (Basel, Switzerland) (2020)

PMID: 32751761

DOI: 10.3390/ph13080174

Cite This Figure

![Figure 487: Opioid receptor cross-talk with cannabinoid signaling in the context of seizure control is illustrated. Mu and kappa opioid receptors may modulate phytocannabinoid efficacy.]()

> Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." *Pharmaceuticals (Basel, Switzerland)*, 2020. PMID: [32751761](https://pubmed.ncbi.nlm.nih.gov/32751761/)

<figure>
  <img src="" alt="Opioid receptor cross-talk with cannabinoid signaling in the context of seizure control is illustrated. Mu and kappa opioid receptors may modulate phytocannabinoid efficacy." />
  <figcaption>Figure 487. Opioid receptor cross-talk with cannabinoid signaling in the context of seizure control is illustrated. Mu and kappa opioid receptors may modulate phytocannabinoid efficacy.<br>  Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751761/">32751761</a></figcaption>
</figure>

Related Evidence

CBD for Insomnia

Grade A · 103 studies